dr. bekaii-saab on tas-102 and regorafenib in mcrc
Published 5 years ago • 147 plays • Length 1:16Download video MP4
Download video MP3
Similar videos
-
0:20
copy of dr. bekaii-saab on tas-102 and regorafenib in mcrc
-
1:50
dr. bekaii-saab on sequencing regorafenib and tas-102 in crc
-
2:24
dr. bekaii saab compares toxicities of regorafenib and tas-102 in colorectal cancer
-
1:23
dr. bekaii-saab on benefits associated with regorafenib or tas-102 for crc
-
2:22
dr. bekaii-saab on differences between regorafenib and tas-102 in crc
-
1:20
dr. bekaii-saab on the use of regorafenib in patients with mcrc
-
1:21
dr. bekaii-saab discusses regorafenib use in mcrc
-
2:13
later-line treatment for mcrc: regorafenib or tas-102?
-
1:16
dr. eng on roles of regorafenib and tas-102 in crc treatment
-
2:26
dr. bekaii-saab on the impact of regorafenib in crc
-
4:53
debate: salvage therapy for mcrc? - tas-102 followed by regorafenib
-
2:22
dr. tanios bekaii-saab on new agents to treat colorectal cancer
-
2:27
dr. bekaii-saab on the redos study in metastatic colorectal cancer
-
1:35
dr. lockhart on next steps for regorafenib and tas-102 in mcrc
-
1:39
dr. bekaii-saab on dosing strategies with regorafenib in crc
-
0:57
choosing between tas-102 and regorafenib in colorectal cancer
-
0:57
dr. bekaii-saab discusses the next steps with regorafenib in crc
-
1:33
dr. bekaii saab on the expansion of treatment options in colorectal cancer
-
5:42
role of tas-102 (trifluridine/tipiracil) in advanced colorectal cancer